Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk
NCT ID: NCT01514539
Last Updated: 2015-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2009-08-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Ghrelin and peptide YY (PYY) are gut hormones involved in appetite regulation and energy homeostasis and are biological neuroendocrine signals that potentially affect body weight and adiposity/
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Breastfeeding on Maternal Plasma Ghrelin and Peptide Tyrosine Tyrosine (PYY) Levels
NCT00831818
Breastfeeding in Infancy and Food Intake in Preschool-Aged Children
NCT00994487
Maternal Obesity, Breast Milk Composition, and Infant Growth
NCT03301753
Breast Milk Hormones and Early Infant Growth of Women With Gestational Diabetes Mellitus
NCT03145649
Human Milk: Understanding the Mechanisms Linked to the Prevention of Obesity and Diabetes in Children Exposed in Utero to Gestational Diabetes
NCT04263675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study evaluated whether fasting or postprandial ghrelin or PYY is different between lactating and nonlactating postpartum women matched for age, body weight, and adiposity.
Eligibility Criteria: Healthy females, 18+ years old, non-smokers, no major food allergies, first-time mom, currently pregnant or within 1 month of giving birth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Four weeks Postpartum Lactating
women between 18 and 45 who delivered their first child 4 weeks prior and who were currently lactating and planning to lactate for one year postpartum.
cross-sectional
Monitoring two recently discovered appetite hormones called "ghrelin" and "neuropeptide YY (PYY)." This study evaluated whether fasting or postprandial ghrelin or PYY is different btween lactating and nonlactating postpartum women matched for age, body weight, and adiposity.
Control Never Pregnant
women between 18 and 45 who have never been pregnant
cross-sectional
Monitoring two recently discovered appetite hormones called "ghrelin" and "neuropeptide YY (PYY)." This study evaluated whether fasting or postprandial ghrelin or PYY is different btween lactating and nonlactating postpartum women matched for age, body weight, and adiposity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cross-sectional
Monitoring two recently discovered appetite hormones called "ghrelin" and "neuropeptide YY (PYY)." This study evaluated whether fasting or postprandial ghrelin or PYY is different btween lactating and nonlactating postpartum women matched for age, body weight, and adiposity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The study is open to women who are breastfeeding or formula feeding.
Exclusion Criteria
* had twins or triples,
* had any major complication of pregnancy(example,
* gestational diabetes);
* have kidney, liver, hormonal, stomach, intestine,lung, heart or blood disease. This also includes high blood pressure;
* use prescription or over-the-counter medicine or herbal drinks or pills.
* History of depression, anxiety, disordered eating, other psychological problems, alcoholism or other substance abuse.
* Severely claustrophobic.
* Having a strong fear of needles and/or do not feel you can have blood drawn every 30 minutes from a plastic catheter.
* Are not able to or willing to fully participate in the study, and are pregnant, anemic or have a thyroid problem.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wyoming
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enette Larson-Meyer
Phd, RD, FACSM
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dawine E. Larson-Meyer, Phd, RD
Role: PRINCIPAL_INVESTIGATOR
University of Wyoming
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nutritional and Exercise Lab University of Wyoming
Laramie, Wyoming, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.